These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
205 related items for PubMed ID: 39307
1. A monitoring test for the liability of neuroleptic drugs to induce tardive dyskinesia. Gunne LM, Bárány S. Psychopharmacology (Berl); 1979 Jun 21; 63(3):195-8. PubMed ID: 39307 [Abstract] [Full Text] [Related]
2. Induction of tardive dyskinesia in Cebus apella and Macaca speciosa monkeys: a review. Domino EF. Psychopharmacology Suppl; 1985 Jun 21; 2():217-23. PubMed ID: 2860660 [Abstract] [Full Text] [Related]
3. The pathophysiology of tardive dyskinesia. Klawans HL, Carvey P, Tanner CM, Goetz CG. J Clin Psychiatry; 1985 Apr 21; 46(4 Pt 2):38-41. PubMed ID: 2858479 [Abstract] [Full Text] [Related]
4. Haloperidol-induced tardive dyskinesia in monkeys. Gunne LM, Bárány S. Psychopharmacology (Berl); 1976 Nov 24; 50(3):237-40. PubMed ID: 826968 [Abstract] [Full Text] [Related]
5. Clozapine in tardive dyskinesia: observations from human and animal model studies. Tamminga CA, Thaker GK, Moran M, Kakigi T, Gao XM. J Clin Psychiatry; 1994 Sep 24; 55 Suppl B():102-6. PubMed ID: 7961550 [Abstract] [Full Text] [Related]
6. Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis. Gunne LM, Häggström JE, Sjöquist B. Nature; 1994 Sep 24; 309(5966):347-9. PubMed ID: 6727989 [Abstract] [Full Text] [Related]
7. Effects of sulpiride on persistent neuroleptic-induced dyskinesia in monkeys. Häggström JE. Acta Psychiatr Scand Suppl; 1984 Sep 24; 311():103-8. PubMed ID: 6142586 [Abstract] [Full Text] [Related]
8. Development of acute dystonia and tardive dyskinesia in cebus monkeys. Bárány S, Ingvast A, Gunne LM. Res Commun Chem Pathol Pharmacol; 1979 Aug 24; 25(2):269-79. PubMed ID: 115074 [Abstract] [Full Text] [Related]
9. Differential striatal levels of TNF-alpha, NFkappaB p65 subunit and dopamine with chronic typical and atypical neuroleptic treatment: role in orofacial dyskinesia. Bishnoi M, Chopra K, Kulkarni SK. Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug 01; 32(6):1473-8. PubMed ID: 18554768 [Abstract] [Full Text] [Related]
10. Fluphenazine-induced acute and tardive dyskinesias in monkeys. Kovacic B, Domino EF. Psychopharmacology (Berl); 1984 Aug 01; 84(3):310-4. PubMed ID: 6440175 [Abstract] [Full Text] [Related]
15. Neuroleptic-induced acute dyskinesias in squirrel monkeys: correlation with propensity to cause extrapyramidal side effects. Liebman J, Neale R. Psychopharmacology (Berl); 1980 Aug 01; 68(1):25-9. PubMed ID: 6104837 [Abstract] [Full Text] [Related]
18. Increased incidence of dyskinesias and other behavioral effects of re-exposure to neuroleptic treatment in social colonies of Cebus apella monkeys. Linn GS, Lifshitz K, O'Keeffe RT, Lee K, Camp-Lifshitz J. Psychopharmacology (Berl); 2001 Jan 01; 153(3):285-94. PubMed ID: 11271400 [Abstract] [Full Text] [Related]